VanEck Pharmaceutical ETF
PPH
PPH
52 hedge funds and large institutions have $113M invested in VanEck Pharmaceutical ETF in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
75% less call options, than puts
Call options by funds: $408K | Put options by funds: $1.65M
Holders
52
Holding in Top 10
–
Calls
$408K
Puts
$1.65M
Top Buyers
| 1 | +$22.8M | |
| 2 | +$3.62M | |
| 3 | +$2.63M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.45M |
| 5 |
CCT
Country Club Trust
Kansas City,
Missouri
|
+$890K |
Top Sellers
| 1 | -$4.56M | |
| 2 | -$1.72M | |
| 3 | -$706K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$688K |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$560K |